increasingly crowded markets in several therapeutic areas are forcing companies to invest in pharmacogenomics research,' notes Sampath. Already, genetic testing has been made easy with the increase in availability of reagents and pharmacogenetics...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Personalised Medicine: An Opportunity for Investment
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account